Sustained Reverse Left Ventricular Structural Remodeling With Cardiac Resynchronization at One Year Is a Function of Etiology
Top Cited Papers
- 17 January 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 113 (2), 266-272
- https://doi.org/10.1161/circulationaha.104.520817
Abstract
Background— Cardiac resynchronization therapy (CRT) is an effective therapy for patients with moderate to severe heart failure and prolonged QRS duration. The purpose of this study was to determine whether reverse left ventricular (LV) remodeling and symptomatic benefit from CRT were sustained at 12 months, and if so, in what proportion of patients this occurred. Methods and Results— Serial Doppler echocardiograms were obtained at baseline and 6 and 12 months after CRT in 228 patients enrolled in the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) trial. Measurements were made of LV end-diastolic (EDV) and end-systolic (ESV) volumes, ejection fraction, LV mass, severity of mitral regurgitation (MR), peak transmitral velocities during early (E wave) and late (A wave) diastolic filling, and myocardial performance index. At both 6 and 12 months, respectively, CRT was associated with reduced LV EDV ( P P =0.007) and LV ESV ( P P P P P =0.012 and P P P P P =0.031, and P P Conclusions— Reverse LV remodeling and symptom benefit with CRT are sustained at 12 months in patients with New York Heart Association class III/IV heart failure but occur to a lesser degree in patients with an ischemic versus a nonischemic etiology, most likely owing to the inexorable progression of ischemic disease.This publication has 15 references indexed in Scilit:
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureThe New England Journal of Medicine, 2005
- Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic dataJournal of the American College of Cardiology, 2004
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureThe New England Journal of Medicine, 2004
- Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 2004
- Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart FailureCirculation, 2003
- Cardiac Resynchronization in Chronic Heart FailureThe New England Journal of Medicine, 2002
- Effects of Multisite Biventricular Pacing in Patients with Heart Failure and Intraventricular Conduction DelayThe New England Journal of Medicine, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureThe New England Journal of Medicine, 1999
- Optimizing the AV Delay in DDD Pacemaker Patients with High Degree AV Block: Mitral Valve Doppler Versus Impedance CardiographyPacing and Clinical Electrophysiology, 1997
- Left Ventricular Remodeling With Carvedilol in Patients With Congestive Heart Failure Due to Ischemic Heart DiseaseJournal of the American College of Cardiology, 1997